by admin | May 28, 2026 | press-releases-rss
This post was originally published on this site.DALLAS, May 28, 2026 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman, President & Chief Executive Officer, will participate in fireside chat presentations at the...
by admin | May 19, 2026 | press-releases-rss
This post was originally published on this site. Patrick Hensley, MD and Daniel Joyce, MD, MS each received a grant up to $50,000.00 to support the development of outstanding clinical cancer research to improve the treatment of NMIBC Last year’s awardees recently...
by admin | May 15, 2026 | press-releases-rss
This post was originally published on this site.– High CR rates at any time observed in the CIS-containing population with 85.7% and 92.3% in the ITT population and Efficacy Evaluable population, respectively – High-Grade – EFS in the overall...
by admin | May 11, 2026 | press-releases-rss
This post was originally published on this site.-First results from CORE-008 Cohort CX Phase 2 Trial evaluating intravesical combination therapy in High-Risk BCG-Exposed and BCG-Unresponsive patients to be presented- -Visit CG Oncology at booth #3051- DALLAS, May 11,...
by admin | May 8, 2026 | press-releases-rss
This post was originally published on this site.Following alignment discussions with FDA, BLA completion for HR BCG-unresponsive NMIBC is expected fourth quarter 2026 PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy as an adjuvant therapy in...
by admin | May 5, 2026 | press-releases-rss
This post was originally published on this site.DALLAS, May 05, 2026 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman & Chief Executive Officer, and Ambaw Bellete, President & Chief Operating Officer, will...